Acrivon Therapeutics, Inc. Common Stock - ACRV
About Gravity Analytica
Recent News
- 10.01.2025 - Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- 10.01.2025 - Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- 08.13.2025 - Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
- 08.13.2025 - Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
Recent Filings
- 09.05.2025 - 8-K Current report
- 09.05.2025 - EX-99.1 EX-99.1
- 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.18.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.18.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.18.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.18.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.18.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 08.13.2025 - 8-K Current report